Delivery of nanoparticles to brain metastases of breast cancer using a cellular Trojan horse

[1]  Игорь Александрович Кутовой.  ONCOLOGY OF THE NERVOUS SYSTEM , 2013 .

[2]  M. Bynoe,et al.  Adenosine Receptor Signaling Modulates Permeability of the Blood–Brain Barrier , 2011, The Journal of Neuroscience.

[3]  P. Steeg,et al.  Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer , 2010, Clinical Cancer Research.

[4]  Robia G. Pautler,et al.  Nanoshells with Targeted Simultaneous Enhancement of Magnetic and Optical Imaging and Photothermal Therapeutic Response , 2009 .

[5]  H. Gendelman,et al.  Macrophage Delivery of Nanoformulated Antiretroviral Drug to the Brain in a Murine Model of NeuroAIDS1 , 2009, The Journal of Immunology.

[6]  Naomi J Halas,et al.  Fluorescence enhancement by Au nanostructures: nanoshells and nanorods. , 2009, ACS nano.

[7]  G. Golomb,et al.  Delivery of serotonin to the brain by monocytes following phagocytosis of liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[8]  N. Lin,et al.  Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer , 2008, Cancer.

[9]  Naomi J Halas,et al.  Nanoshells made easy: improving Au layer growth on nanoparticle surfaces. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[10]  Naomi J Halas,et al.  Nanoscale control of near-infrared fluorescence enhancement using Au nanoshells. , 2008, Small.

[11]  Jennifer Sturgis,et al.  A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. , 2007, Nano letters.

[12]  K. Hynynen,et al.  Chemotherapy delivery issues in central nervous system malignancy: a reality check. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  S. Steinberg,et al.  Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. , 2007, Cancer research.

[14]  E. Winer,et al.  Brain Metastases: The HER2 Paradigm , 2007, Clinical Cancer Research.

[15]  Glenn P. Goodrich,et al.  Plasmonic enhancement of molecular fluorescence. , 2007, Nano letters.

[16]  V. Heinemann,et al.  Characteristics of patients with brain metastases receiving trastuzumab for HER2 overexpressing metastatic breast cancer. , 2006, Breast.

[17]  C. Swanton,et al.  Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab , 2006, Acta oncologica.

[18]  E. Winer,et al.  Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  R. Weil,et al.  Breast cancer metastasis to the central nervous system. , 2005, The American journal of pathology.

[20]  S. Lo,et al.  Stereotactic radiosurgery with and without whole-brain radiotherapy for newly diagnosed brain metastases , 2005, Expert review of neurotherapeutics.

[21]  A. Howell,et al.  Incidence of cerebral metastases in patients treated with trastuzumab for metastatic breast cancer , 2004, British Journal of Cancer.

[22]  Jill S Barnholtz-Sloan,et al.  Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  D. Begley,et al.  ABC transporters and the blood-brain barrier. , 2004, Current pharmaceutical design.

[24]  A. Twijnstra,et al.  Neurologic disorders in 432 consecutive patients with small cell lung carcinoma , 2004, Cancer.

[25]  C. L. Graff,et al.  Drug transport at the blood-brain barrier and the choroid plexus. , 2004, Current drug metabolism.

[26]  E. Winer,et al.  Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma , 2003, Cancer.

[27]  W. Regine,et al.  The Rationale for Adjuvant Whole Brain Radiation Therapy with Radiosurgery in the Treatment of Single Brain Metastases , 2003, Technology in cancer research & treatment.

[28]  P. Wen,et al.  Neurologic Complications of Cancer , 2003 .

[29]  G. Barnett,et al.  Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study. , 2002, International journal of radiation oncology, biology, physics.

[30]  Paul J. Williams,et al.  A Bone‐Seeking Clone Exhibits Different Biological Properties from the MDA‐MB‐231 Parental Human Breast Cancer Cells and a Brain‐Seeking Clone In Vivo and In Vitro , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  A. Twijnstra,et al.  Asymptomatic Brain Metastases (BM) in Small Cell Lung Cancer (SCLC): MR-imaging is Useful at Initial Diagnosis , 2000, Journal of Neuro-Oncology.

[32]  M. Sands,et al.  Behavior and Therapeutic Efficacy of β-Glucuronidase–Positive Mononuclear Phagocytes in a Murine Model of Mucopolysaccharidosis Type VII , 1999 .

[33]  V. Budach,et al.  Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: long-term follow-up and investigations of late neuropsychologic effects. , 1999, Journal of Clinical Oncology.

[34]  P. Wen,et al.  Management of brain metastases. , 1999, Oncology.

[35]  Susan M. Chang,et al.  Radiosurgery for brain metastases: is whole brain radiotherapy necessary? , 1999, International journal of radiation oncology, biology, physics.

[36]  J. Abkowitz,et al.  Mature monocytic cells enter tissues and engraft. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Naomi J. Halas,et al.  Nanoengineering of optical resonances , 1998 .

[38]  R. Sawaya,et al.  Neurologic Complications of Cancer. , 1996 .

[39]  Peter P. Edwards,et al.  A new hydrosol of gold clusters. 1. Formation and particle size variation , 1993 .

[40]  D. Hume,et al.  Macrophage infiltration into experimental brain metastases: occurrence through an intact blood-brain barrier. , 1988, Journal of the National Cancer Institute.

[41]  A. Walker,et al.  Epidemiology of brain tumors , 1985, Neurology.

[42]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 2: studies of the macrophage content of human brain tumors. , 1979, Journal of neurosurgery.

[43]  K. Gollahon,et al.  Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity. , 1979, Journal of neurosurgery.

[44]  W. Pardridge.  The blood-brain barrier: Bottleneck in brain drug development , 2005, NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.

[45]  R. Meyermann,et al.  Immune cell infiltration of intrinsic and metastatic intracranial tumours. , 2004, Anticancer research.

[46]  A. Ardizzoni,et al.  The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer. , 2001, Critical reviews in oncology/hematology.

[47]  M. Sands,et al.  Behavior and therapeutic efficacy of beta-glucuronidase-positive mononuclear phagocytes in a murine model of mucopolysaccharidosis type VII. , 1999, Blood.

[48]  A. Baiker,et al.  A new hydrosol of gold clusters , 1993 .

[49]  W. Stöber,et al.  Controlled growth of monodisperse silica spheres in the micron size range , 1968 .